With the help of current investor Elevar Equity, health tech platform Curebay has received Rs 61.8 crore, or $7.5 million, in a fresh funding round. Elevar Equity led the round with 60 crore, while additional investors, including the CEO, CTO, and other members of the executive team at Curebay, invested a total of Rs 1.6 crore.
Read also – Country Delight Raises $20 Mn in Series E Round
According to its regulatory documents obtained from the Registrar of Companies (RoC), Curebay’s board approved a resolution to issue 4,80,590 Series A1 CCPS at an issue price of Rs 1287.12 apiece in order to generate Rs 61.8 crore, or $7.5 million, as reported by Entrackr.com.
Read also – Sourcefit Raises Investment From 9 Basil, NextGen Ventures, and Rocket Equities
About Curebay
Founded in 2021, CureBay has a vision to transform patient experience in the underserved markets by bridging the gap, which exists in primary healthcare. CureBay introducing a hybrid healthcare and fulfilment model that helps connect patients in underserved markets to healthcare providers and other key ecosystem players digitally, and executing it through a robust 3-tier model of Hub, Spoke and a network of satellite health centres.
Read also – TDK Ventures invests in Silicon Box and its revolutionary chiplet technology
